Cargando…
Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea
To compare the standardized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence of high epicenter region with non-epicenter region, serological studies were performed with a total of 3,268 sera from Daegu City and 3,981 sera from Chungbuk Province. Indirect immunofluorescence...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Microbiological Society of Korea
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/ https://www.ncbi.nlm.nih.gov/pubmed/33907974 http://dx.doi.org/10.1007/s12275-021-1095-7 |
_version_ | 1783685181458087936 |
---|---|
author | Jeong, Hye Won Chang, Hyun-Ha Kim, Eun Ji Kim, Yu Kyung Kim, Se-Mi Kim, Eun-Ha Kim, Young-Il Casel, Mark Anthony B. Kim, Seong-Gyu Rollon, Rare Jang, Seung-Gyu Yu, Kwang-Min Kim, Hee-Sung Park, Hee Sue Park, Su-Jin Kim, Yong-Dae Kim, Eung-Gook Choi, Young Ki |
author_facet | Jeong, Hye Won Chang, Hyun-Ha Kim, Eun Ji Kim, Yu Kyung Kim, Se-Mi Kim, Eun-Ha Kim, Young-Il Casel, Mark Anthony B. Kim, Seong-Gyu Rollon, Rare Jang, Seung-Gyu Yu, Kwang-Min Kim, Hee-Sung Park, Hee Sue Park, Su-Jin Kim, Yong-Dae Kim, Eung-Gook Choi, Young Ki |
author_sort | Jeong, Hye Won |
collection | PubMed |
description | To compare the standardized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence of high epicenter region with non-epicenter region, serological studies were performed with a total of 3,268 sera from Daegu City and 3,981 sera from Chungbuk Province. Indirect immunofluorescence assay (IFA) for SARS-CoV-2 IgG results showed a high seroprevalence rate in the Daegu City (epicenter) compared with a non-epicenter area (Chungbuk Province) (1.27% vs. 0.91%, P = 0.0358). It is noteworthy that the highest seroprevalence in Daegu City was found in elderly patients (70’s) whereas young adult patients (20’s) in Chungbuk Province showed the highest seroprevalence. Neutralizing antibody (NAb) titers were found in three samples from Daegu City (3/3, 268, 0.09%) while none of the samples from Chungbuk Province were NAb positive. These results demonstrated that even following the large outbreak, the seropositive rate of SARS-CoV-2 in the general population remained low in South Korea. |
format | Online Article Text |
id | pubmed-8079228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Microbiological Society of Korea |
record_format | MEDLINE/PubMed |
spelling | pubmed-80792282021-04-28 Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea Jeong, Hye Won Chang, Hyun-Ha Kim, Eun Ji Kim, Yu Kyung Kim, Se-Mi Kim, Eun-Ha Kim, Young-Il Casel, Mark Anthony B. Kim, Seong-Gyu Rollon, Rare Jang, Seung-Gyu Yu, Kwang-Min Kim, Hee-Sung Park, Hee Sue Park, Su-Jin Kim, Yong-Dae Kim, Eung-Gook Choi, Young Ki J Microbiol Virology To compare the standardized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence of high epicenter region with non-epicenter region, serological studies were performed with a total of 3,268 sera from Daegu City and 3,981 sera from Chungbuk Province. Indirect immunofluorescence assay (IFA) for SARS-CoV-2 IgG results showed a high seroprevalence rate in the Daegu City (epicenter) compared with a non-epicenter area (Chungbuk Province) (1.27% vs. 0.91%, P = 0.0358). It is noteworthy that the highest seroprevalence in Daegu City was found in elderly patients (70’s) whereas young adult patients (20’s) in Chungbuk Province showed the highest seroprevalence. Neutralizing antibody (NAb) titers were found in three samples from Daegu City (3/3, 268, 0.09%) while none of the samples from Chungbuk Province were NAb positive. These results demonstrated that even following the large outbreak, the seropositive rate of SARS-CoV-2 in the general population remained low in South Korea. The Microbiological Society of Korea 2021-04-28 2021 /pmc/articles/PMC8079228/ /pubmed/33907974 http://dx.doi.org/10.1007/s12275-021-1095-7 Text en © The Microbiological Society of Korea 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Virology Jeong, Hye Won Chang, Hyun-Ha Kim, Eun Ji Kim, Yu Kyung Kim, Se-Mi Kim, Eun-Ha Kim, Young-Il Casel, Mark Anthony B. Kim, Seong-Gyu Rollon, Rare Jang, Seung-Gyu Yu, Kwang-Min Kim, Hee-Sung Park, Hee Sue Park, Su-Jin Kim, Yong-Dae Kim, Eung-Gook Choi, Young Ki Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
title | Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
title_full | Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
title_fullStr | Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
title_full_unstemmed | Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
title_short | Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
title_sort | differences in seroprevalence between epicenter and non-epicenter areas of the covid-19 outbreak in south korea |
topic | Virology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/ https://www.ncbi.nlm.nih.gov/pubmed/33907974 http://dx.doi.org/10.1007/s12275-021-1095-7 |
work_keys_str_mv | AT jeonghyewon differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT changhyunha differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimeunji differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimyukyung differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimsemi differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimeunha differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimyoungil differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT caselmarkanthonyb differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimseonggyu differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT rollonrare differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT jangseunggyu differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT yukwangmin differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimheesung differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT parkheesue differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT parksujin differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimyongdae differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT kimeunggook differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea AT choiyoungki differencesinseroprevalencebetweenepicenterandnonepicenterareasofthecovid19outbreakinsouthkorea |